Effects of Platelet-Rich Fibrin in Patients With Anterior Cruciate Ligament Reconstruction
NCT ID: NCT05904158
Last Updated: 2023-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
30 participants
INTERVENTIONAL
2010-06-15
2022-08-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Blood Flow Restriction Training on Patient With Anterior Cruciate Ligament Reconstruction
NCT04284748
Clinical and Radiological Evaluation of ACL Reconstruction Results
NCT05504018
The Effectıveness Of Structured Myofascial Chain Exercise Training After Anterior Cruciate Ligament Reconstruction
NCT05423184
Comparison of Remnant-Preserving Anterior Cruciate Ligament Reconstruction With Healthy Controls
NCT05245461
Clinical and Functional Outcomes After ACL Reconstruction Versus Primary Repair
NCT07318272
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PRF Group
Patients in this group, received PRF application during the standard ACL reconstruction surgery
Platelet-Rich Fibrin during Standard ACL reconstruction surgery
Plateleth-rich fibrin was obtained from patients own blood (40 cc) and applied to the tunnels which were drilled for ACL graft
Control Group
Patients in this group received a standard ACL reconstruction surgery without any other intervention.
Standard ACL reconstruction surgery
This was a control group where patients received Standard ACL reconstruction surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Platelet-Rich Fibrin during Standard ACL reconstruction surgery
Plateleth-rich fibrin was obtained from patients own blood (40 cc) and applied to the tunnels which were drilled for ACL graft
Standard ACL reconstruction surgery
This was a control group where patients received Standard ACL reconstruction surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being between the ages of 18-45 years,
* Performing sports recreationally or professionally
Exclusion Criteria
* Having systematic disease,
* Having multiple ligament injury on the knee or additional cartilage injuries
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara City Hospital Bilkent
OTHER
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
SERDAR DEMIRCI
Dr. Fzt. Serdar Demirci (Director of the study)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-18-2060
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.